The fertility results of each group over the course of the 4-month mating trial.

Note: Group A: negative female controls without CTx treatment; Group B: female mice administered nonlethal doses of CTx (busulfan 30 mg/kg, cyclophosphamide 120 mg/kg) without transplantation of FGSCs; Group C: female mice administered the same dose of CTx as Group B, with the transplantation of FGSCs one week after the CTx; Group D: female mice administered the same dose of CTx as Group B, with the transplantation of FGSCs two months after the CTx; Group E:female mice administered median lethal doses (LD50) of CTx (busulfan 20 mg/kg, cyclophosphamide 200 mg/kg), without the transplantation of FGSCs; Group F: female mice administered the same dose of CTx as Group E, with the transplantation of FGSCs one week after the CTx. I: the offspring number of the first generation; II: the offspring number of the second generation; III: the offspring number of the third generation; CO: the offspring number during continuous observation over the course of the 4-month mating trial.
The fertility results of each group over the course of the 4-month mating trial.